Posts Tagged ‘pandemic

December 05, 2022
Our Take: Published data from the Phase III Clarity trial support positive top-line results for investigational Alzheimer’s drug lecanemab
Read More
December 02, 2022
Podcast 156: Maximizing Value by Meeting People Where They Are, with Rob Allen, FACHE
Read More
November 21, 2022
Our Take: Sanford Health and Fairview Health Services will make another run at merging
Read More
November 18, 2022
Podcast 155: Complex Population Health Management and Comprehensive Value-Based Models for High-Risk Patients, with Dr. Robert Jarve
Read More
November 14, 2022
Our Take: With investments by Walgreens and Evernorth, VillageMD to acquire Summit Health-CityMD for $8.9 billion
Read More
November 07, 2022
Our Take: CMS hopes new changes to the Medicare Shared Savings Program will increase participation
Read More
November 04, 2022
Podcast 154: Reimagining a High-Touch, Whole-Person Care Model for Kidney Disease, with Jackson Brasher
Read More
October 31, 2022
Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts
Read More
October 24, 2022
Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports
Read More
October 21, 2022
Podcast 153: Overcoming the Costly Roadblocks to Developing Novel Cancer Therapies, with Dr. David Stewart
Read More
October 17, 2022
Our Take: Ransomware attack continues to disrupt business at CommonSpirit
Read More
October 10, 2022
Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues
Read More
October 07, 2022
Podcast 152: Tracking the Ever-Changing Life Science Landscape with BioPharmGuy’s Adam Wilson
Read More
October 03, 2022
Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial
Read More

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Gainey Corporate Center
8777 N. Gainey Center Drive, Suite 205 Scottsdale AZ 85258
1 (888) 402-3465

Posts Tagged ‘pandemic

Our Take: Published data from the Phase III Clarity trial support positive top-line results for investigational Alzheimer’s drug lecanemab

Podcast 156: Maximizing Value by Meeting People Where They Are, with Rob Allen, FACHE

Our Take: Sanford Health and Fairview Health Services will make another run at merging

Podcast 155: Complex Population Health Management and Comprehensive Value-Based Models for High-Risk Patients, with Dr. Robert Jarve

Our Take: With investments by Walgreens and Evernorth, VillageMD to acquire Summit Health-CityMD for $8.9 billion

Our Take: CMS hopes new changes to the Medicare Shared Savings Program will increase participation

Podcast 154: Reimagining a High-Touch, Whole-Person Care Model for Kidney Disease, with Jackson Brasher

Our Take: Centene to switch PBMs in 2024, awarding new contract to Express Scripts

Our Take: Analysts predict Apple will enter the health insurance market in 2024, Forbes reports

Podcast 153: Overcoming the Costly Roadblocks to Developing Novel Cancer Therapies, with Dr. David Stewart

Our Take: Ransomware attack continues to disrupt business at CommonSpirit

Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues

Podcast 152: Tracking the Ever-Changing Life Science Landscape with BioPharmGuy’s Adam Wilson

Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial

Sign up for Our Take
the weekly strategic brief for Health Care Executives

share

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Stay Connected

Posts Tagged ‘pandemic

Sign up for Our Takethe weekly strategic brief for Health Care Executives

share

Contact Darwin Research Group and we will get right back to you.

Reach out to us

Sign up for Our Takethe weekly strategic brief for Health Care Executives

Stay Connected

Sign up for Our Take
the weekly strategic brief for Health Care Executives

Sign up for Our Take
the weekly strategic brief for Health Care Executives